PAIN RELIEVER

PAIN RELIEVER was reported 260500 times

PAIN RELIEVER is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PYROGLUTAMIC ACIDOSIS 308 0.7758
1 VAGINAL FLATULENCE 225 0.7426
2 APPENDICOLITH 285 0.7364
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 420 0.6287
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4464 0.6224
5 RHEUMATIC FEVER 2761 0.6188
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 1220 0.6091
7 DUODENAL ULCER PERFORATION 4510 0.6059
8 SWOLLEN JOINT COUNT INCREASED 1920 0.6015
9 C-REACTIVE PROTEIN 543 0.5858
10 LUPUS VULGARIS 716 0.5683
11 EXPOSURE TO TOXIC AGENT 1696 0.5297
12 FACET JOINT SYNDROME 1714 0.5259
13 BLOOD PRESSURE DIASTOLIC ABNORMAL 1293 0.5079
14 BLOOD PRESSURE SYSTOLIC ABNORMAL 1195 0.4830
15 RHEUMATOID FACTOR POSITIVE 2792 0.4829
16 MUSCLE INJURY 3818 0.4603
17 HELICOBACTER INFECTION 4573 0.4445
18 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2809 0.4321
19 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 892 0.4301
20 FOLLICULITIS 4350 0.4144
21 PEMPHIGUS 5073 0.4054
22 X-RAY ABNORMAL 716 0.4000
23 HAND DEFORMITY 5205 0.3965
24 DISLOCATION OF VERTEBRA 883 0.3868
25 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 214 0.3815
26 ANALGESIC DRUG LEVEL INCREASED 595 0.3705
27 ANION GAP 214 0.3375
28 PERIPHERAL VENOUS DISEASE 1305 0.3192
29 SYNOVITIS 5668 0.3140
30 RETINITIS 539 0.3117
31 PERICARDITIS 5160 0.3068
32 C-REACTIVE PROTEIN ABNORMAL 1880 0.2928
33 MULTIPLE DRUG THERAPY 211 0.2798
34 SERONEGATIVE ARTHRITIS 278 0.2426
35 AMAUROSIS FUGAX 252 0.2340
36 SEDATION COMPLICATION 595 0.2330
37 GLOSSODYNIA 5101 0.2276
38 INFUSION SITE DISCHARGE 391 0.2228
39 PORPHYRIA ACUTE 305 0.2125
40 ACUTE HEPATIC FAILURE 2849 0.2083
41 IRRITABLE BOWEL SYNDROME 4368 0.2035
42 BREAST CANCER STAGE III 1287 0.1985
43 LIP DRY 1741 0.1915
44 DRUG TOLERANCE DECREASED 530 0.1885
45 WOUND 5233 0.1870
46 BURSITIS 2265 0.1865
47 BONE EROSION 657 0.1856
48 PHARYNGEAL PARAESTHESIA 291 0.1832
49 ONYCHOMADESIS 760 0.1809
50 HYPERCHOLESTEROLAEMIA 1729 0.1789
51 BLOOD PRESSURE DIASTOLIC DECREASED 1308 0.1770
52 JOINT RANGE OF MOTION DECREASED 2325 0.1732
53 INFUSION RELATED REACTION 11357 0.1712
54 POISONING DELIBERATE 1614 0.1701
55 GRIP STRENGTH DECREASED 1497 0.1699
56 WOUND INFECTION 1855 0.1692
57 INFUSION SITE PRURITUS 525 0.1662
58 CONTRAINDICATED PRODUCT ADMINISTERED 4930 0.1627
59 HEPATIC CYTOLYSIS 2066 0.1619
60 FEMALE GENITAL TRACT FISTULA 273 0.1597
61 ONYCHOMYCOSIS 696 0.1585
62 SYSTEMIC LUPUS ERYTHEMATOSUS 5590 0.1573
63 INFUSION SITE BRUISING 339 0.1568
64 LIVER INJURY 3802 0.1547
65 LIVE BIRTH 1243 0.1484
66 SUSPECTED SUICIDE 693 0.1477
67 EAR PRURITUS 517 0.1473
68 BLOOD PRESSURE DIASTOLIC INCREASED 677 0.1465
69 CREATININE RENAL CLEARANCE DECREASED 581 0.1450
70 BLOOD PRESSURE FLUCTUATION 3428 0.1427
71 IMPAIRED HEALING 4665 0.1419
72 TEMPERATURE REGULATION DISORDER 316 0.1417
73 INFUSION SITE HAEMORRHAGE 465 0.1412
74 BLOOD PRESSURE SYSTOLIC INCREASED 2704 0.1385
75 BLEPHAROSPASM 870 0.1380
76 AUTOIMMUNE DISORDER 1332 0.1365
77 FIBROMYALGIA 3273 0.1345
78 HYPERPHOSPHATAEMIA 287 0.1334
79 SCHIZOAFFECTIVE DISORDER 234 0.1311
80 WHITE BLOOD CELLS URINE POSITIVE 245 0.1301
81 PHYSICAL DECONDITIONING 334 0.1297
82 FINGER DEFORMITY 624 0.1287
83 LOWER RESPIRATORY TRACT INFECTION 5848 0.1285
84 INFUSION SITE SWELLING 796 0.1264
85 INFUSION SITE REACTION 373 0.1247
86 HYPERPARATHYROIDISM SECONDARY 298 0.1188
87 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1288 0.1163
88 HEPATIC NECROSIS 429 0.1138
89 CLOSTRIDIUM TEST POSITIVE 248 0.1124
90 RADICULOPATHY 296 0.1122
91 CHRONIC SINUSITIS 418 0.1113
92 MATERNAL EXPOSURE TIMING UNSPECIFIED 416 0.1106
93 NEPHROGENIC ANAEMIA 509 0.1098
94 ARTHROPATHY 5996 0.1078
95 SCIATICA 1707 0.1070
96 BODY TEMPERATURE DECREASED 1041 0.1056
97 NAIL DISORDER 924 0.1055
98 MULTIPLE DRUG OVERDOSE 519 0.1045
99 BLOOD PHOSPHORUS INCREASED 283 0.1035
100 HEPATITIS FULMINANT 307 0.1034
101 THERAPEUTIC PRODUCT EFFECT DECREASED 4627 0.1032
102 TYPE 2 DIABETES MELLITUS 3469 0.1029
103 HEPATIC ENZYME INCREASED 6978 0.1023
104 PERSONALITY DISORDER 267 0.1018
105 COMPLETED SUICIDE 8484 0.1017
106 PROCTITIS 285 0.1016
107 PLEURITIC PAIN 277 0.1003
108 INTENTIONAL OVERDOSE 6396 0.0996
109 MIXED LIVER INJURY 300 0.0996
110 TOXICITY TO VARIOUS AGENTS 16809 0.0996
111 OBESITY 1586 0.0994
112 INFUSION SITE ERYTHEMA 838 0.0993
113 INFUSION SITE EXTRAVASATION 617 0.0990
114 POOR VENOUS ACCESS 1016 0.0981
115 INFUSION SITE PAIN 1265 0.0981
116 WALKING AID USER 647 0.0980
117 METHAEMOGLOBINAEMIA 226 0.0975
118 AUTISM SPECTRUM DISORDER 520 0.0944
119 BLISTER 5225 0.0929
120 METABOLIC ACIDOSIS 2966 0.0927
121 INCORRECT DRUG ADMINISTRATION RATE 383 0.0899
122 BRONCHIECTASIS 600 0.0890
123 MULTIPLE DRUG OVERDOSE INTENTIONAL 283 0.0879
124 COELIAC DISEASE 860 0.0876
125 PULMONARY FIBROSIS 1653 0.0861
126 DEVICE INFUSION ISSUE 212 0.0854
127 SUSPECTED OFF LABEL USE 386 0.0854
128 C-REACTIVE PROTEIN INCREASED 3100 0.0851
129 ALCOHOL POISONING 228 0.0850
130 SINUSITIS 8669 0.0845
131 LUNG OPACITY 222 0.0842
132 STOMATITIS 5089 0.0838
133 DRUG TOXICITY 1142 0.0838
134 IRON DEFICIENCY 375 0.0833
135 PRESCRIBED OVERDOSE 1598 0.0825
136 DISCOMFORT 5012 0.0821
137 INTENTIONAL PRODUCT USE ISSUE 7151 0.0815
138 MULTIPLE ALLERGIES 639 0.0814
139 EXOSTOSIS 744 0.0814
140 RHEUMATOID ARTHRITIS 9203 0.0810
141 JAUNDICE CHOLESTATIC 286 0.0809
142 RED CELL DISTRIBUTION WIDTH INCREASED 332 0.0798
143 CYTOKINE RELEASE SYNDROME 1601 0.0797
144 DRUG-INDUCED LIVER INJURY 2501 0.0796
145 HEPATITIS ACUTE 516 0.0793
146 PRODUCT LABEL CONFUSION 462 0.0792
147 BLOOD CHOLESTEROL INCREASED 3681 0.0789
148 BODY TEMPERATURE INCREASED 1611 0.0789
149 HEPATOTOXICITY 1742 0.0782
150 BLOOD CALCIUM DECREASED 874 0.0776
151 HYPOPNOEA 268 0.0771
152 HEART RATE DECREASED 2707 0.0770
153 SWELLING 7211 0.0770
154 PSORIATIC ARTHROPATHY 3108 0.0765
155 JOINT SWELLING 9242 0.0765
156 HIP ARTHROPLASTY 1171 0.0764
157 RESPIRATORY RATE INCREASED 671 0.0755
158 NIGHT SWEATS 2425 0.0752
159 DRUG INTOLERANCE 7242 0.0749
160 FOOD ALLERGY 578 0.0748
161 MUSCLE SPASTICITY 916 0.0745
162 BACK INJURY 803 0.0738
163 MONOCYTE COUNT INCREASED 266 0.0732
164 MACULAR DEGENERATION 873 0.0730
165 END STAGE RENAL DISEASE 1332 0.0730
166 LOWER LIMB FRACTURE 1403 0.0729
167 RALES 424 0.0729
168 JOINT DISLOCATION 766 0.0724
169 FOOT DEFORMITY 798 0.0719
170 APLASTIC ANAEMIA 374 0.0715
171 BLOOD CREATININE DECREASED 223 0.0711
172 OSTEOARTHRITIS 3006 0.0708
173 PUSTULAR PSORIASIS 243 0.0707
174 COAGULOPATHY 1160 0.0695
175 PNEUMONIA VIRAL 221 0.0693
176 CYTOLYTIC HEPATITIS 230 0.0692
177 URINARY TRACT DISORDER 312 0.0692
178 EAR PAIN 1345 0.0691
179 ILL-DEFINED DISORDER 4141 0.0681
180 GAIT INABILITY 2260 0.0676
181 OXYGEN SATURATION DECREASED 3790 0.0674
182 MOBILITY DECREASED 4840 0.0673
183 TOXIC EPIDERMAL NECROLYSIS 1020 0.0671
184 SPONDYLITIS 242 0.0665
185 HYPOMANIA 240 0.0652
186 HEPATIC ENCEPHALOPATHY 609 0.0652
187 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 330 0.0651
188 LIVER FUNCTION TEST INCREASED 1396 0.0650
189 INFLAMMATION 3349 0.0648
190 ORTHOSTATIC HYPOTENSION 1127 0.0647
191 VASCULAR DEVICE INFECTION 293 0.0645
192 BREATH SOUNDS ABNORMAL 318 0.0644
193 AORTIC STENOSIS 223 0.0640
194 LUPUS-LIKE SYNDROME 580 0.0639
195 EAR INFECTION 1673 0.0628
196 WHEEZING 3713 0.0626
197 ULCER HAEMORRHAGE 423 0.0624
198 SUICIDE ATTEMPT 3786 0.0624
199 CONGENITAL ANOMALY 483 0.0623
200 BLOOD PRESSURE SYSTOLIC DECREASED 280 0.0615
201 HYPERTRANSAMINASAEMIA 427 0.0613
202 MAJOR DEPRESSION 447 0.0611
203 SEASONAL ALLERGY 861 0.0608
204 CARDIAC MURMUR 526 0.0607
205 HYPOPHOSPHATAEMIA 447 0.0604
206 URINE ABNORMALITY 274 0.0602
207 MUSCULOSKELETAL STIFFNESS 5248 0.0598
208 GASTROINTESTINAL DISORDER 5346 0.0596
209 FOETAL DEATH 309 0.0595
210 WEIGHT FLUCTUATION 622 0.0594
211 RHINITIS 479 0.0593
212 DELIRIUM 2057 0.0592
213 RASH VESICULAR 286 0.0591
214 FEBRILE NEUTROPENIA 3920 0.0590
215 RESPIRATORY DEPRESSION 722 0.0588
216 ACIDOSIS 447 0.0584
217 DEPRESSED LEVEL OF CONSCIOUSNESS 2309 0.0583
218 UPPER RESPIRATORY TRACT INFECTION 2691 0.0582
219 KNEE ARTHROPLASTY 1223 0.0580
220 BLOOD URIC ACID INCREASED 334 0.0578
221 COVID-19 PNEUMONIA 680 0.0575
222 HAEMORRHAGIC STROKE 448 0.0573
223 DRUG LEVEL BELOW THERAPEUTIC 314 0.0569
224 HEPATITIS CHOLESTATIC 338 0.0561
225 HEPATIC FAILURE 1687 0.0559
226 POISONING 701 0.0557
227 GENERAL PHYSICAL HEALTH DETERIORATION 6335 0.0547
228 ATELECTASIS 529 0.0547
229 HEPATITIS 1400 0.0547
230 ATTENTION DEFICIT HYPERACTIVITY DISORDER 230 0.0546
231 IMMUNODEFICIENCY 814 0.0546
232 LUNG DISORDER 2637 0.0538
233 MATERNAL EXPOSURE DURING PREGNANCY 4746 0.0532
234 DRUG USE DISORDER 447 0.0531
235 OEDEMA 2880 0.0531
236 RESPIRATORY TRACT INFECTION 1382 0.0530
237 SEDATION 1389 0.0530
238 BRAIN OEDEMA 668 0.0528
239 ANAL FISSURE 282 0.0525
240 CHOLESTASIS 1007 0.0524
241 NORMAL NEWBORN 285 0.0524
242 LYMPHOCYTE COUNT DECREASED 920 0.0520
243 INJURY 3658 0.0520
244 PRESCRIBED UNDERDOSE 1037 0.0519
245 SEROTONIN SYNDROME 998 0.0519
246 BREAST CANCER STAGE II 432 0.0519
247 NASOPHARYNGITIS 9499 0.0515
248 RENAL TUBULAR NECROSIS 503 0.0512
249 PROTHROMBIN TIME PROLONGED 306 0.0511
250 CONTUSION 4901 0.0509
251 NEUTROPHIL COUNT INCREASED 519 0.0506
252 APHTHOUS ULCER 393 0.0506
253 CONFUSIONAL STATE 8184 0.0506
254 TASTE DISORDER 1025 0.0505
255 INSURANCE ISSUE 771 0.0504
256 SLEEP DISORDER 3557 0.0503
257 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 389 0.0500
258 HYPOXIA 1763 0.0500
259 JOINT EFFUSION 345 0.0500
260 CARDIO-RESPIRATORY ARREST 2091 0.0500
261 HYPERAMMONAEMIA 250 0.0499
262 INFECTION 7215 0.0498
263 TREATMENT FAILURE 4116 0.0496
264 DRUG LEVEL INCREASED 822 0.0496
265 BLOOD LACTIC ACID INCREASED 261 0.0495
266 SKIN LACERATION 538 0.0494
267 TROPONIN INCREASED 375 0.0492
268 PERIPHERAL SWELLING 7592 0.0492
269 MUSCULOSKELETAL PAIN 2563 0.0489
270 ORAL CANDIDIASIS 643 0.0488
271 LIVER DISORDER 2165 0.0488
272 MYOSITIS 438 0.0488
273 CHRONIC KIDNEY DISEASE 3697 0.0486
274 SPUTUM DISCOLOURED 461 0.0486
275 ASPIRATION 532 0.0485
276 RHINITIS ALLERGIC 216 0.0485
277 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 825 0.0481
278 APPENDICITIS 448 0.0479
279 TUBULOINTERSTITIAL NEPHRITIS 898 0.0479
280 HYPOTHERMIA 485 0.0479
281 VASCULITIS 558 0.0479
282 ABDOMINAL TENDERNESS 237 0.0477
283 THROAT IRRITATION 2136 0.0476
284 ENCEPHALOPATHY 1169 0.0476
285 COMA 2255 0.0473
286 ACUTE KIDNEY INJURY 7244 0.0473
287 MYASTHENIA GRAVIS 382 0.0472
288 GANGRENE 284 0.0471
289 MEDICATION ERROR 2617 0.0470
290 SINUS CONGESTION 633 0.0468
291 SKIN INFECTION 524 0.0467
292 HYPERSENSITIVITY 8661 0.0466
293 LEUKOCYTOSIS 843 0.0465
294 BENIGN PROSTATIC HYPERPLASIA 240 0.0464
295 TRANSAMINASES INCREASED 1029 0.0462
296 DRUG LEVEL ABOVE THERAPEUTIC 211 0.0460
297 RESPIRATORY DISORDER 1368 0.0457
298 GENERALISED OEDEMA 565 0.0456
299 SKIN ABRASION 214 0.0452
300 GINGIVAL PAIN 360 0.0452
301 ALANINE AMINOTRANSFERASE INCREASED 2771 0.0451
302 CLOSTRIDIUM DIFFICILE COLITIS 478 0.0450
303 HAEMODYNAMIC INSTABILITY 343 0.0450
304 INTERNATIONAL NORMALISED RATIO INCREASED 1279 0.0448
305 CARDIOGENIC SHOCK 642 0.0447
306 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 264 0.0445
307 HEART RATE IRREGULAR 1006 0.0445
308 HYPOALBUMINAEMIA 346 0.0445
309 EXPOSURE DURING PREGNANCY 2765 0.0444
310 HEPATIC CIRRHOSIS 835 0.0444
311 ABDOMINAL DISCOMFORT 7443 0.0443
312 SENSORY LOSS 357 0.0443
313 ROAD TRAFFIC ACCIDENT 1844 0.0440
314 SINUS TACHYCARDIA 619 0.0435
315 JOINT STIFFNESS 1137 0.0433
316 BACTERAEMIA 513 0.0432
317 NEUTROPENIC SEPSIS 308 0.0431
318 BLOOD PRESSURE INCREASED 6579 0.0430
319 PYREXIA 14822 0.0428
320 HYPERTENSION 9018 0.0425
321 CYSTITIS 1355 0.0425
322 MIOSIS 341 0.0424
323 HYPERBILIRUBINAEMIA 440 0.0424
324 ARTERIOSCLEROSIS CORONARY ARTERY 281 0.0424
325 HAEMATOCRIT DECREASED 841 0.0424
326 ULCER 674 0.0423
327 INTRACRANIAL PRESSURE INCREASED 234 0.0420
328 ASPARTATE AMINOTRANSFERASE INCREASED 2226 0.0419
329 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2005 0.0417
330 TACHYCARDIA 3690 0.0415
331 HYPERTHERMIA 317 0.0415
332 COORDINATION ABNORMAL 578 0.0414
333 TENDERNESS 431 0.0413
334 DRY MOUTH 3353 0.0413
335 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1170 0.0413
336 OSTEOPOROSIS 1686 0.0409
337 SUBSTANCE ABUSE 333 0.0409
338 PERIORBITAL OEDEMA 212 0.0408
339 ASPHYXIA 333 0.0407
340 ACCIDENTAL OVERDOSE 1488 0.0406
341 OVERDOSE 8756 0.0405
342 PREGNANCY 812 0.0405
343 BRONCHITIS 3001 0.0405
344 BLOOD ALKALINE PHOSPHATASE INCREASED 1004 0.0404
345 BLOOD ALBUMIN DECREASED 319 0.0402
346 DERMATITIS CONTACT 458 0.0401
347 BLOOD TEST ABNORMAL 564 0.0401
348 FLANK PAIN 374 0.0399
349 EPILEPSY 1218 0.0398
350 PHARYNGITIS 493 0.0397
351 WEIGHT INCREASED 8900 0.0397
352 TOOTH ABSCESS 403 0.0395
353 HYPOTENSION 7935 0.0395
354 TACHYPNOEA 537 0.0395
355 TOOTH INFECTION 520 0.0394
356 THERAPY NON-RESPONDER 1773 0.0394
357 RASH MACULO-PAPULAR 876 0.0393
358 ALTERED STATE OF CONSCIOUSNESS 851 0.0392
359 RECTAL HAEMORRHAGE 1671 0.0389
360 POSTOPERATIVE WOUND INFECTION 261 0.0386
361 BLOOD BILIRUBIN INCREASED 1042 0.0385
362 ASCITES 1124 0.0382
363 HYPOGAMMAGLOBULINAEMIA 251 0.0382
364 FREQUENT BOWEL MOVEMENTS 1031 0.0381
365 BACTERIAL INFECTION 712 0.0381
366 HYPOVOLAEMIA 222 0.0379
367 ARTERIAL OCCLUSIVE DISEASE 298 0.0379
368 PHARYNGITIS STREPTOCOCCAL 408 0.0377
369 NEURALGIA 915 0.0376
370 MIGRAINE 3556 0.0372
371 UNRESPONSIVE TO STIMULI 961 0.0372
372 VENTRICULAR FIBRILLATION 412 0.0371
373 HYPOKALAEMIA 1708 0.0370
374 LOCALISED INFECTION 892 0.0368
375 SCHIZOPHRENIA 447 0.0367
376 HYPONATRAEMIA 2069 0.0367
377 BLOOD UREA INCREASED 615 0.0367
378 GAMMA-GLUTAMYLTRANSFERASE INCREASED 813 0.0366
379 INTENTIONAL SELF-INJURY 737 0.0365
380 HEAD DISCOMFORT 645 0.0364
381 ADVERSE REACTION 483 0.0364
382 NECK PAIN 2033 0.0363
383 PARAESTHESIA ORAL 524 0.0363
384 RENAL CYST 288 0.0362
385 PULMONARY MASS 540 0.0362
386 ARTHRITIS 2839 0.0361
387 HEMIPLEGIA 300 0.0360
388 HEPATOCELLULAR INJURY 509 0.0359
389 HAEMOLYSIS 277 0.0358
390 PNEUMONIA 11598 0.0358
391 STEVENS-JOHNSON SYNDROME 796 0.0358
392 PYELONEPHRITIS 310 0.0357
393 GASTROOESOPHAGEAL REFLUX DISEASE 2875 0.0357
394 ABDOMINAL PAIN 8306 0.0357
395 URTICARIA 5969 0.0356
396 COGNITIVE DISORDER 1660 0.0355
397 ARTHRALGIA 14750 0.0354
398 EYE INFECTION 400 0.0354
399 DYSPEPSIA 3484 0.0354
400 BLOOD CALCIUM INCREASED 310 0.0353
401 HAEMATEMESIS 896 0.0353
402 UPPER GASTROINTESTINAL HAEMORRHAGE 594 0.0353
403 HYPERAESTHESIA 290 0.0353
404 PRODUCTIVE COUGH 1684 0.0352
405 OCULAR DISCOMFORT 396 0.0352
406 LYMPHOEDEMA 243 0.0351
407 MOTOR DYSFUNCTION 358 0.0351
408 UROSEPSIS 324 0.0351
409 SINUS DISORDER 695 0.0351
410 RESPIRATORY ARREST 962 0.0349
411 BLOOD CREATININE INCREASED 2278 0.0349
412 PRESYNCOPE 848 0.0348
413 ANGIOEDEMA 1528 0.0345
414 OLIGURIA 214 0.0344
415 ALOPECIA 6747 0.0343
416 HYPOAESTHESIA 5135 0.0343
417 DUODENAL ULCER 242 0.0343
418 OROPHARYNGEAL DISCOMFORT 309 0.0342
419 POST-TRAUMATIC STRESS DISORDER 229 0.0341
420 ACUTE RESPIRATORY DISTRESS SYNDROME 603 0.0341
421 SEPSIS 3802 0.0341
422 ACUTE RESPIRATORY FAILURE 655 0.0340
423 ADRENAL INSUFFICIENCY 413 0.0340
424 RESPIRATORY SYNCYTIAL VIRUS INFECTION 295 0.0338
425 HEPATIC STEATOSIS 631 0.0338
426 PULMONARY CONGESTION 445 0.0337
427 PNEUMONIA ASPIRATION 843 0.0337
428 PURPURA 298 0.0336
429 CONDITION AGGRAVATED 10233 0.0336
430 SPINAL OSTEOARTHRITIS 295 0.0335
431 HEART RATE INCREASED 3320 0.0335
432 PSEUDOMONAS INFECTION 287 0.0334
433 CARDIOMEGALY 411 0.0334
434 MUSCULAR WEAKNESS 3796 0.0334
435 UPPER-AIRWAY COUGH SYNDROME 275 0.0333
436 HEPATOMEGALY 328 0.0333
437 ARTHROPOD BITE 247 0.0333
438 INTENTIONAL PRODUCT MISUSE 2917 0.0333
439 MENTAL STATUS CHANGES 923 0.0332
440 GASTROENTERITIS VIRAL 600 0.0332
441 PNEUMONIA BACTERIAL 304 0.0331
442 ANAPHYLACTIC REACTION 1828 0.0331
443 EOSINOPHIL COUNT INCREASED 275 0.0330
444 HYDRONEPHROSIS 247 0.0330
445 PHOTOPHOBIA 619 0.0329
446 MOUTH ULCERATION 692 0.0328
447 SARS-COV-2 TEST POSITIVE 433 0.0328
448 SPINAL DISORDER 310 0.0327
449 OEDEMA PERIPHERAL 3985 0.0327
450 GASTROINTESTINAL INFECTION 293 0.0327
451 CELLULITIS 1645 0.0326
452 JOINT INJURY 697 0.0326
453 AGRANULOCYTOSIS 604 0.0325
454 TRICUSPID VALVE INCOMPETENCE 258 0.0324
455 MUSCLE RIGIDITY 388 0.0324
456 VAGINAL DISCHARGE 326 0.0322
457 PRODUCT USE ISSUE 6055 0.0322
458 MYOCARDITIS 369 0.0322
459 RESPIRATORY DISTRESS 888 0.0321
460 TUMOUR LYSIS SYNDROME 282 0.0320
461 LIVER FUNCTION TEST ABNORMAL 931 0.0320
462 IRON DEFICIENCY ANAEMIA 295 0.0319
463 KIDNEY INFECTION 627 0.0319
464 VIRAL INFECTION 1063 0.0319
465 OBSTRUCTIVE AIRWAYS DISORDER 355 0.0319
466 NEPHROPATHY 297 0.0318
467 COVID-19 5580 0.0318
468 MALNUTRITION 355 0.0317
469 PANCREATITIS ACUTE 713 0.0317
470 WHITE BLOOD CELL COUNT INCREASED 1215 0.0316
471 CHOLELITHIASIS 1038 0.0316
472 ESCHERICHIA INFECTION 260 0.0316
473 PLEURAL EFFUSION 1922 0.0316
474 VOMITING 14841 0.0315
475 ABDOMINAL PAIN UPPER 6497 0.0315
476 BRADYCARDIA 1666 0.0314
477 POST PROCEDURAL INFECTION 255 0.0313
478 INTERVERTEBRAL DISC DEGENERATION 290 0.0313
479 DRUG INTERACTION 4969 0.0313
480 LIGAMENT SPRAIN 309 0.0312
481 RESPIRATORY TRACT CONGESTION 496 0.0312
482 URINARY TRACT INFECTION 5308 0.0311
483 SMALL INTESTINAL OBSTRUCTION 383 0.0311
484 LYMPHOPENIA 439 0.0310
485 ERYTHEMA MULTIFORME 289 0.0310
486 MUSCULOSKELETAL CHEST PAIN 479 0.0309
487 GASTROENTERITIS 450 0.0308
488 EOSINOPHILIA 540 0.0308
489 DECUBITUS ULCER 251 0.0308
490 OSTEOPENIA 467 0.0307
491 CHILLS 3594 0.0306
492 COLITIS 1161 0.0306
493 PAIN 18790 0.0306
494 OESOPHAGITIS 334 0.0305
495 ASTHMA 3444 0.0304
496 SINUS BRADYCARDIA 294 0.0304
497 PRODUCT DISTRIBUTION ISSUE 282 0.0304
498 DRUG ABUSE 2528 0.0303
499 CONCUSSION 235 0.0303
500 PAROSMIA 229 0.0303
501 AFFECT LABILITY 292 0.0303
502 SEPTIC SHOCK 1319 0.0303
503 EMPHYSEMA 305 0.0302
504 THROMBOCYTOPENIA 3381 0.0302
505 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5447 0.0302
506 INFLUENZA 3365 0.0301
507 HYPOMAGNESAEMIA 419 0.0301
508 CANDIDA INFECTION 508 0.0301
509 NASAL CONGESTION 1766 0.0300
510 OROPHARYNGEAL PAIN 2777 0.0300
511 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 771 0.0299
512 RENAL INJURY 890 0.0299
513 SHOCK 689 0.0299
514 DRUG LEVEL DECREASED 304 0.0298
515 PULMONARY OEDEMA 1337 0.0298
516 DERMATITIS BULLOUS 216 0.0298
517 CHEST PAIN 5523 0.0298
518 MYDRIASIS 382 0.0297
519 JAUNDICE 800 0.0297
520 RASH 12952 0.0297
521 APNOEA 231 0.0296
522 GOUT 532 0.0296
523 SUBARACHNOID HAEMORRHAGE 302 0.0296
524 VITAMIN D DEFICIENCY 288 0.0295
525 ATRIAL FLUTTER 235 0.0294
526 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2095 0.0294
527 PALLOR 801 0.0294
528 RIB FRACTURE 605 0.0294
529 HAEMOGLOBIN DECREASED 3019 0.0294
530 SLEEP APNOEA SYNDROME 561 0.0294
531 BLOOD LACTATE DEHYDROGENASE INCREASED 464 0.0293
532 ANAL INCONTINENCE 263 0.0292
533 BLOOD MAGNESIUM DECREASED 252 0.0292
534 HEMIPARESIS 494 0.0291
535 HYPERKALAEMIA 1022 0.0291
536 RED BLOOD CELL COUNT DECREASED 833 0.0291
537 NODULE 379 0.0290
538 FACE OEDEMA 489 0.0290
539 COUGH 8126 0.0289
540 ABSCESS 462 0.0289
541 PHARYNGEAL SWELLING 283 0.0289
542 ECONOMIC PROBLEM 438 0.0289
543 SOMNOLENCE 5804 0.0288
544 DISABILITY 570 0.0288
545 BLOOD URINE PRESENT 546 0.0287
546 URINE OUTPUT DECREASED 251 0.0287
547 RENAL FAILURE 3810 0.0287
548 TOOTH FRACTURE 316 0.0286
549 SWOLLEN TONGUE 895 0.0286
550 SHOCK HAEMORRHAGIC 233 0.0286
551 HYPERLIPIDAEMIA 342 0.0286
552 PNEUMONITIS 778 0.0285
553 INTENTIONAL DRUG MISUSE 594 0.0284
554 NEPHROLITHIASIS 1303 0.0284
555 CLOSTRIDIUM DIFFICILE INFECTION 620 0.0284
556 DIVERTICULITIS 786 0.0283
557 HERPES ZOSTER 1627 0.0283
558 BLOOD PRESSURE DECREASED 1876 0.0282
559 FACIAL PAIN 251 0.0281
560 NEPHROPATHY TOXIC 315 0.0280
561 RHINORRHOEA 1811 0.0280
562 MUCOSAL INFLAMMATION 733 0.0280
563 NERVE COMPRESSION 258 0.0279
564 HEADACHE 17507 0.0279
565 RENAL FAILURE ACUTE 1184 0.0279
566 FLUID RETENTION 1417 0.0278
567 AMNESIA 1812 0.0278
568 FOOT FRACTURE 528 0.0278
569 ARTERIOSCLEROSIS 262 0.0278
570 GASTRIC ULCER 529 0.0278
571 WEIGHT DECREASED 7768 0.0278
572 CARDIAC ARREST 2294 0.0278
573 HAEMOPTYSIS 775 0.0278
574 TOOTHACHE 502 0.0277
575 PETECHIAE 289 0.0277
576 FACIAL PARALYSIS 236 0.0277
577 HYPERCALCAEMIA 341 0.0276
578 HYPOGLYCAEMIA 1338 0.0276
579 PLATELET COUNT INCREASED 359 0.0275
580 MYOCLONUS 328 0.0275
581 BLOOD IRON DECREASED 326 0.0274
582 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 282 0.0274
583 POOR QUALITY SLEEP 591 0.0274
584 FATIGUE 21341 0.0274
585 BACK PAIN 6331 0.0272
586 DYSPNOEA 15377 0.0271
587 EATING DISORDER 578 0.0271
588 FISTULA 305 0.0271
589 MITRAL VALVE INCOMPETENCE 307 0.0271
590 COLITIS ULCERATIVE 1211 0.0271
591 HAEMATURIA 925 0.0270
592 OFF LABEL USE 23639 0.0270
593 RESPIRATORY FAILURE 1961 0.0269
594 HAEMATOMA 695 0.0268
595 RHABDOMYOLYSIS 1115 0.0267
596 ASTHENIA 10044 0.0267
597 TOOTH DISORDER 593 0.0266
598 SKIN ULCER 689 0.0266
599 DECREASED APPETITE 6181 0.0266
600 LIMB INJURY 722 0.0266
601 HIATUS HERNIA 344 0.0265
602 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 219 0.0265
603 PANCYTOPENIA 1483 0.0265
604 PAIN IN EXTREMITY 7801 0.0264
605 RASH ERYTHEMATOUS 1264 0.0264
606 MULTI-ORGAN FAILURE 457 0.0264
607 LACTIC ACIDOSIS 856 0.0264
608 ELECTROLYTE IMBALANCE 307 0.0264
609 FALL 8789 0.0264
610 MELAENA 581 0.0264
611 DIPLOPIA 685 0.0263
612 ANAEMIA 5014 0.0263
613 NEUTROPHIL COUNT DECREASED 1071 0.0263
614 BLOOD SODIUM DECREASED 493 0.0261
615 NEUROLEPTIC MALIGNANT SYNDROME 310 0.0261
616 CYANOSIS 411 0.0261
617 DENTAL CARIES 289 0.0261
618 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1361 0.0261
619 FEELING HOT 1598 0.0260
620 TOXIC SKIN ERUPTION 262 0.0260
621 PRURITUS 9993 0.0260
622 ORAL HERPES 507 0.0259
623 LEUKOPENIA 1298 0.0259
624 SPINAL PAIN 304 0.0259
625 CHOLECYSTITIS 309 0.0259
626 FEELING COLD 721 0.0259
627 TRANSFUSION 271 0.0258
628 FOETAL EXPOSURE DURING PREGNANCY 2101 0.0258
629 CONSTIPATION 5636 0.0258
630 CHEST DISCOMFORT 2646 0.0258
631 BLADDER DISORDER 256 0.0258
632 BALANCE DISORDER 2225 0.0257
633 WRIST FRACTURE 308 0.0257
634 ABDOMINAL DISTENSION 2671 0.0256
635 HAEMORRHOIDS 498 0.0255
636 HALLUCINATION, VISUAL 537 0.0254
637 ELECTROCARDIOGRAM QT PROLONGED 910 0.0253
638 NIGHTMARE 875 0.0253
639 BLOOD POTASSIUM INCREASED 410 0.0252
640 CONJUNCTIVITIS 468 0.0252
641 DISSEMINATED INTRAVASCULAR COAGULATION 355 0.0252
642 MICTURITION URGENCY 287 0.0251
643 HAEMATOCHEZIA 1386 0.0251
644 IMMUNOSUPPRESSION 221 0.0250
645 TINNITUS 1151 0.0250
646 FULL BLOOD COUNT ABNORMAL 264 0.0249
647 ANGINA PECTORIS 714 0.0249
648 LUNG INFILTRATION 220 0.0249
649 THROAT TIGHTNESS 671 0.0248
650 DYSPNOEA EXERTIONAL 934 0.0248
651 DEVICE RELATED INFECTION 381 0.0247
652 PULMONARY EMBOLISM 2352 0.0247
653 HYPERHIDROSIS 3177 0.0246
654 SNEEZING 553 0.0246
655 DYSARTHRIA 927 0.0246
656 TEMPERATURE INTOLERANCE 254 0.0246
657 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 418 0.0246
658 MALAISE 10781 0.0246
659 PULMONARY HYPERTENSION 512 0.0246
660 GLOMERULAR FILTRATION RATE DECREASED 302 0.0246
661 UVEITIS 333 0.0245
662 CATARACT 1461 0.0245
663 GASTRITIS 644 0.0244
664 HERNIA 471 0.0243
665 BACK DISORDER 396 0.0243
666 INSOMNIA 6473 0.0243
667 BLOOD PRESSURE ABNORMAL 481 0.0242
668 PERIPHERAL COLDNESS 332 0.0242
669 DECREASED IMMUNE RESPONSIVENESS 237 0.0241
670 CYST 299 0.0241
671 EAR DISCOMFORT 246 0.0239
672 DRUG ERUPTION 423 0.0238
673 BASAL CELL CARCINOMA 372 0.0238
674 MUSCULOSKELETAL DISCOMFORT 410 0.0238
675 DIABETES MELLITUS INADEQUATE CONTROL 419 0.0236
676 PARAESTHESIA 3717 0.0236
677 PAIN IN JAW 667 0.0235
678 NAUSEA 18626 0.0235
679 NEUTROPENIA 3191 0.0234
680 PSYCHOTIC DISORDER 693 0.0234
681 THERAPEUTIC RESPONSE SHORTENED 778 0.0234
682 ATRIAL FIBRILLATION 2279 0.0234
683 HYPERGLYCAEMIA 851 0.0233
684 STAPHYLOCOCCAL INFECTION 769 0.0233
685 PANCREATITIS 1229 0.0232
686 SUPRAVENTRICULAR TACHYCARDIA 222 0.0232
687 MASS 324 0.0232
688 PERICARDIAL EFFUSION 536 0.0232
689 PNEUMOTHORAX 367 0.0231
690 URINARY RETENTION 772 0.0231
691 SPLENOMEGALY 270 0.0230
692 HYPOTONIA 230 0.0230
693 PRODUCT USE IN UNAPPROVED INDICATION 5700 0.0230
694 BRONCHOSPASM 328 0.0230
695 HYPOCALCAEMIA 435 0.0230
696 HOSPICE CARE 227 0.0230
697 FUNGAL INFECTION 765 0.0229
698 AGITATION 1679 0.0228
699 VENTRICULAR TACHYCARDIA 376 0.0227
700 LETHARGY 1310 0.0227
701 DYSPHAGIA 2160 0.0227
702 APHASIA 685 0.0227
703 SYNCOPE 2267 0.0226
704 DEHYDRATION 3013 0.0226
705 GAIT DISTURBANCE 4314 0.0225
706 EJECTION FRACTION DECREASED 347 0.0223
707 RESTLESSNESS 813 0.0222
708 ILEUS 276 0.0222
709 OSTEOMYELITIS 402 0.0222
710 MEMORY IMPAIRMENT 3033 0.0221
711 INTERVERTEBRAL DISC PROTRUSION 481 0.0220
712 PLATELET COUNT DECREASED 2345 0.0220
713 PROTEINURIA 418 0.0220
714 INJECTION SITE EXTRAVASATION 271 0.0219
715 PRODUCT ADMINISTRATION ERROR 442 0.0218
716 DIZZINESS POSTURAL 212 0.0218
717 DIARRHOEA 14054 0.0218
718 SKIN LESION 596 0.0217
719 LYMPHADENOPATHY 767 0.0216
720 POST PROCEDURAL COMPLICATION 413 0.0215
721 VERTIGO 1310 0.0215
722 MUSCLE TWITCHING 495 0.0215
723 DEEP VEIN THROMBOSIS 1394 0.0214
724 ILLNESS 2196 0.0213
725 ANAPHYLACTIC SHOCK 547 0.0212
726 DEPRESSION 4816 0.0211
727 IMPAIRED QUALITY OF LIFE 303 0.0211
728 SWELLING FACE 1372 0.0210
729 RESTLESS LEGS SYNDROME 382 0.0210
730 ADVERSE DRUG REACTION 1885 0.0210
731 SUDDEN DEATH 222 0.0210
732 DRY THROAT 213 0.0209
733 BLOOD CREATINE PHOSPHOKINASE INCREASED 602 0.0209
734 URINARY INCONTINENCE 619 0.0209
735 ANXIETY 5941 0.0209
736 ANHEDONIA 548 0.0208
737 CARDIOMYOPATHY 307 0.0208
738 EYE PAIN 1166 0.0206
739 ROTATOR CUFF SYNDROME 265 0.0206
740 INCONTINENCE 218 0.0206
741 DIZZINESS 10286 0.0206
742 MUSCLE SPASMS 3784 0.0206
743 SKIN HAEMORRHAGE 305 0.0206
744 MYOCARDIAL ISCHAEMIA 234 0.0205
745 SKIN REACTION 289 0.0205
746 FAECES DISCOLOURED 442 0.0204
747 ERYTHEMA 4188 0.0204
748 HYPOPHAGIA 519 0.0203
749 GALLBLADDER DISORDER 362 0.0203
750 DYSPHONIA 1184 0.0202
751 DYSURIA 745 0.0202
752 HYPOKINESIA 293 0.0202
753 DISORIENTATION 797 0.0201
754 ATAXIA 238 0.0200
755 ACCIDENT 239 0.0200
756 RASH PRURITIC 1083 0.0200
757 GLAUCOMA 384 0.0199
758 TENDONITIS 308 0.0199
759 DECREASED ACTIVITY 214 0.0198
760 BLOOD POTASSIUM DECREASED 595 0.0198
761 INTERSTITIAL LUNG DISEASE 956 0.0197
762 LIP SWELLING 656 0.0197
763 INCORRECT PRODUCT ADMINISTRATION DURATION 426 0.0196
764 BRAIN FOG 308 0.0196
765 APHONIA 274 0.0196
766 WHITE BLOOD CELL COUNT DECREASED 2127 0.0196
767 EPISTAXIS 1467 0.0196
768 DEPRESSED MOOD 1031 0.0195
769 FLUSHING 1979 0.0194
770 HALLUCINATION 1467 0.0194
771 SCAR 332 0.0194
772 HIP FRACTURE 623 0.0194
773 SECRETION DISCHARGE 242 0.0193
774 ANKLE FRACTURE 299 0.0193
775 SUBDURAL HAEMATOMA 276 0.0193
776 CARPAL TUNNEL SYNDROME 270 0.0193
777 LIMB DISCOMFORT 594 0.0192
778 INFLUENZA LIKE ILLNESS 1577 0.0191
779 THERAPY PARTIAL RESPONDER 297 0.0190
780 HYPOTHYROIDISM 608 0.0190
781 GENERALISED TONIC-CLONIC SEIZURE 315 0.0190
782 INTESTINAL PERFORATION 213 0.0190
783 HEAD INJURY 600 0.0189
784 ISCHAEMIC STROKE 338 0.0189
785 NEUROPATHY PERIPHERAL 1801 0.0189
786 PALPITATIONS 2203 0.0188
787 RENAL IMPAIRMENT 1580 0.0188
788 ORAL PAIN 419 0.0187
789 FEEDING DISORDER 379 0.0187
790 CIRCULATORY COLLAPSE 318 0.0187
791 ADVERSE EVENT 1718 0.0186
792 HEPATIC FUNCTION ABNORMAL 693 0.0185
793 PROCEDURAL PAIN 515 0.0185
794 SPINAL FRACTURE 371 0.0185
795 BEDRIDDEN 243 0.0185
796 CYTOMEGALOVIRUS INFECTION 306 0.0184
797 EYE DISORDER 605 0.0184
798 EYELID OEDEMA 213 0.0183
799 CORONARY ARTERY DISEASE 554 0.0183
800 IMPAIRED WORK ABILITY 391 0.0183
801 IMPAIRED GASTRIC EMPTYING 244 0.0179
802 HYPERSOMNIA 513 0.0179
803 ACUTE MYOCARDIAL INFARCTION 526 0.0178
804 DEVICE OCCLUSION 251 0.0178
805 PHOTOSENSITIVITY REACTION 294 0.0178
806 INTESTINAL OBSTRUCTION 671 0.0178
807 LABORATORY TEST ABNORMAL 523 0.0177
808 ARRHYTHMIA 835 0.0176
809 HALLUCINATION, AUDITORY 280 0.0176
810 CHROMATURIA 395 0.0175
811 MYALGIA 2974 0.0175
812 BLINDNESS 711 0.0174
813 CHOKING 339 0.0174
814 GASTROINTESTINAL HAEMORRHAGE 1452 0.0174
815 UNDERDOSE 1267 0.0173
816 CARDIAC FAILURE 1384 0.0172
817 DYSSTASIA 499 0.0171
818 BONE DISORDER 311 0.0170
819 GINGIVAL BLEEDING 233 0.0170
820 METASTASES TO BONE 280 0.0170
821 DELUSION 265 0.0170
822 PREMATURE BABY 513 0.0170
823 TREMOR 2816 0.0169
824 LOSS OF CONSCIOUSNESS 2169 0.0169
825 PULMONARY ARTERIAL HYPERTENSION 245 0.0169
826 SKIN DISORDER 563 0.0169
827 COLD SWEAT 297 0.0168
828 THERAPEUTIC RESPONSE DECREASED 1020 0.0168
829 THROMBOSIS 1352 0.0168
830 DERMATITIS ALLERGIC 211 0.0168
831 THYROID DISORDER 258 0.0167
832 TRANSIENT ISCHAEMIC ATTACK 564 0.0167
833 METASTASES TO CENTRAL NERVOUS SYSTEM 215 0.0167
834 BONE DENSITY DECREASED 522 0.0166
835 MOVEMENT DISORDER 533 0.0166
836 HOT FLUSH 1246 0.0165
837 UPPER LIMB FRACTURE 328 0.0164
838 ABDOMINAL PAIN LOWER 416 0.0164
839 FLUID OVERLOAD 238 0.0163
840 RASH PAPULAR 365 0.0163
841 SEIZURE 1879 0.0163
842 HYPOAESTHESIA ORAL 244 0.0162
843 DEMENTIA 451 0.0161
844 HAEMORRHAGE INTRACRANIAL 241 0.0161
845 TOOTH LOSS 334 0.0161
846 FEMUR FRACTURE 496 0.0160
847 RETCHING 339 0.0159
848 HYPERTHYROIDISM 230 0.0159
849 BONE PAIN 928 0.0158
850 MUSCULOSKELETAL DISORDER 299 0.0157
851 RASH MACULAR 549 0.0157
852 DIABETES MELLITUS 1194 0.0156
853 PARALYSIS 224 0.0156
854 VISUAL IMPAIRMENT 1935 0.0156
855 MUSCLE TIGHTNESS 251 0.0155
856 SENSORY DISTURBANCE 247 0.0154
857 LACRIMATION INCREASED 464 0.0153
858 LUNG INFECTION 238 0.0153
859 PARANOIA 263 0.0152
860 DISEASE PROGRESSION 1792 0.0151
861 ECZEMA 789 0.0151
862 DISTURBANCE IN ATTENTION 811 0.0150
863 DRY EYE 750 0.0150
864 TREATMENT NONCOMPLIANCE 820 0.0150
865 RENAL DISORDER 696 0.0149
866 SPEECH DISORDER 778 0.0148
867 PREMATURE DELIVERY 235 0.0147
868 DYSKINESIA 592 0.0146
869 PSYCHOMOTOR HYPERACTIVITY 241 0.0145
870 DRUG INEFFECTIVE 19001 0.0144
871 POLLAKIURIA 601 0.0144
872 NEUROTOXICITY 252 0.0144
873 CEREBRAL HAEMORRHAGE 513 0.0143
874 SKIN DISCOLOURATION 658 0.0143
875 PERITONITIS 295 0.0142
876 MULTIPLE FRACTURES 231 0.0140
877 ACUTE MYELOID LEUKAEMIA 219 0.0140
878 BONE MARROW FAILURE 285 0.0140
879 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 769 0.0140
880 FULL BLOOD COUNT DECREASED 282 0.0140
881 INTENTIONAL DOSE OMISSION 398 0.0139
882 EYE SWELLING 515 0.0138
883 THIRST 246 0.0138
884 LYMPHOMA 212 0.0137
885 DEAFNESS 358 0.0137
886 BURNING SENSATION 958 0.0136
887 METASTASES TO LIVER 239 0.0136
888 VISION BLURRED 1861 0.0135
889 PRODUCT DOSE OMISSION ISSUE 3964 0.0135
890 MIDDLE INSOMNIA 251 0.0134
891 NERVOUS SYSTEM DISORDER 418 0.0134
892 FEELING JITTERY 249 0.0131
893 DYSGEUSIA 966 0.0130
894 MENTAL DISORDER 563 0.0129
895 CARDIAC FAILURE CONGESTIVE 1036 0.0129
896 PRODUCT AVAILABILITY ISSUE 293 0.0129
897 PRODUCT PRESCRIBING ERROR 306 0.0128
898 INJECTION SITE REACTION 872 0.0127
899 HAEMORRHAGE 1324 0.0127
900 FLATULENCE 716 0.0126
901 PLASMA CELL MYELOMA 490 0.0125
902 SKIN CANCER 270 0.0125
903 SKIN FISSURES 244 0.0125
904 BLOOD TRIGLYCERIDES INCREASED 220 0.0124
905 DISEASE RECURRENCE 590 0.0124
906 SUICIDAL IDEATION 1135 0.0124
907 AGGRESSION 619 0.0124
908 FRACTURE 234 0.0123
909 PSORIASIS 1577 0.0121
910 CEREBROVASCULAR ACCIDENT 2026 0.0119
911 CARDIAC DISORDER 1112 0.0119
912 GASTRIC DISORDER 405 0.0118
913 MENTAL IMPAIRMENT 286 0.0118
914 FEAR 316 0.0117
915 CRYING 420 0.0115
916 PANIC ATTACK 421 0.0115
917 ABNORMAL BEHAVIOUR 454 0.0114
918 MALIGNANT NEOPLASM PROGRESSION 1170 0.0114
919 NERVOUSNESS 596 0.0114
920 NEOPLASM PROGRESSION 395 0.0113
921 INCREASED APPETITE 217 0.0113
922 DYSTONIA 220 0.0113
923 CEREBRAL INFARCTION 275 0.0112
924 DEATH 9651 0.0112
925 CONVULSION 638 0.0111
926 FEELING ABNORMAL 2662 0.0111
927 OCULAR HYPERAEMIA 521 0.0110
928 CARDIOVASCULAR DISORDER 277 0.0109
929 EYE PRURITUS 364 0.0108
930 OSTEONECROSIS 355 0.0108
931 HOSPITALISATION 1616 0.0105
932 DERMATITIS 220 0.0105
933 DRUG EXPOSURE DURING PREGNANCY 352 0.0103
934 MULTIPLE SCLEROSIS 494 0.0103
935 SKIN EXFOLIATION 867 0.0103
936 PRODUCT PRESCRIBING ISSUE 222 0.0102
937 EMOTIONAL DISTRESS 1233 0.0102
938 PRODUCT DOSE OMISSION IN ERROR 288 0.0102
939 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 236 0.0101
940 DIABETIC KETOACIDOSIS 241 0.0100
941 HYPOACUSIS 430 0.0100
942 INCORRECT DOSE ADMINISTERED 2264 0.0099
943 AGEUSIA 242 0.0097
944 PAIN OF SKIN 261 0.0097
945 IRRITABILITY 566 0.0094
946 MYOCARDIAL INFARCTION 1640 0.0094
947 NEOPLASM MALIGNANT 623 0.0093
948 EXTRAPYRAMIDAL DISORDER 231 0.0093
949 BLOOD GLUCOSE DECREASED 437 0.0091
950 UNEVALUABLE EVENT 685 0.0090
951 OSTEONECROSIS OF JAW 224 0.0090
952 NEEDLE ISSUE 261 0.0090
953 RASH GENERALISED 231 0.0089
954 THERAPY INTERRUPTED 629 0.0088
955 MOOD SWINGS 278 0.0087
956 MOOD ALTERED 231 0.0085
957 ANGER 284 0.0084
958 LUNG NEOPLASM MALIGNANT 339 0.0082
959 ABORTION SPONTANEOUS 330 0.0082
960 EMOTIONAL DISORDER 249 0.0081
961 MULTIPLE SCLEROSIS RELAPSE 541 0.0079
962 BLOOD GLUCOSE INCREASED 1487 0.0079
963 SURGERY 453 0.0077
964 WITHDRAWAL SYNDROME 324 0.0077
965 EYE IRRITATION 442 0.0077
966 DRUG ADMINISTRATION ERROR 232 0.0076
967 ACNE 564 0.0074
968 DEVICE DISLOCATION 315 0.0072
969 DRY SKIN 952 0.0071
970 PRODUCT QUALITY ISSUE 950 0.0070
971 EXPIRED PRODUCT ADMINISTERED 227 0.0068
972 THERAPEUTIC RESPONSE UNEXPECTED 272 0.0061
973 VAGINAL HAEMORRHAGE 261 0.0060
974 DRUG DEPENDENCE 922 0.0057
975 THERAPY CESSATION 291 0.0057
976 INJECTION SITE ERYTHEMA 654 0.0053
977 INJECTION SITE SWELLING 393 0.0051
978 SKIN IRRITATION 224 0.0049
979 INJECTION SITE PRURITUS 316 0.0047
980 BREAST CANCER 420 0.0045
981 DRUG WITHDRAWAL SYNDROME 384 0.0044
982 NO ADVERSE EVENT 776 0.0043
983 DEVICE ISSUE 373 0.0042
984 DRUG EFFECT DECREASED 223 0.0041
985 INJECTION SITE BRUISING 312 0.0039
986 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 269 0.0038
987 INJECTION SITE PAIN 1143 0.0037
988 ACCIDENTAL EXPOSURE TO PRODUCT 365 0.0035
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 682 0.0034
990 INJECTION SITE HAEMORRHAGE 262 0.0033
991 SKIN BURNING SENSATION 229 0.0032
992 DEVICE MALFUNCTION 220 0.0031
993 PROSTATE CANCER 225 0.0028
994 DRUG DOSE OMISSION 333 0.0020